Literature DB >> 11122916

Epi-inositol and inositol depletion: two new treatment approaches in affective disorder.

Y Bersudsky1, H Einat, Z Stahl, R H Belmaker.   

Abstract

Inositol is a simple polyol precursor in a second messenger system important in brain myo-insitol, the natural isomer, which has been found to be therapeutically effective in depression, panic disorder, and obsessive-compulsive disorder in double-blind controlled trials. Recently, epi-inositol, an unnatural stereoisomer of myo-inositol, was found to have effects similar to those of myo-inositol to reverse lithium-pilocarpine seizures. We measured the behavior of rats in an elevated plus maze model of anxiety after chronic treatment of 11 daily intraperitoneal injections of epi-inositol, myo-inositol, or control solution. Epi-inositol reduced anxiety levels of rats compared with controls, and its effect was stronger than that of myo- inositol. Lithium has been hypothesized to alleviate mania by reducing brain inositol levels. Inositol in brain derives from the second messenger cycle, from new synthesis, or from diet via transport across the blood brain barrier. Because the first two are inhibited by lithium, we propose that an inositol-free diet will augment lithium action in mania by enhancing restriction of inositol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122916     DOI: 10.1007/s11920-999-0023-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  20 in total

1.  A comparison of the ability of myo-inositol and epi-inositol to attenuate lithium-pilocarpine seizures in rats.

Authors:  Y Patishi; R H Belmaker; Y Bersudsky; O Kofman
Journal:  Biol Psychiatry       Date:  1996-05-01       Impact factor: 13.382

2.  Controlled trials of inositol in psychiatry.

Authors:  J Levine
Journal:  Eur Neuropsychopharmacol       Date:  1997-05       Impact factor: 4.600

3.  Epi-inositol is biochemically active in reversing lithium effects on cytidine monophosphorylphosphatidate (CMP-PA). Short communication.

Authors:  M H Richards; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Neural and developmental actions of lithium: a unifying hypothesis.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

5.  Distribution and properties of CDP-diglyceride:inositol transferase from brain.

Authors:  J A Benjamins; B W Agranoff
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

6.  CSF inositol does not predict antidepressant response to inositol. Short communication.

Authors:  J Levine; L Kurtzman; A Rapoport; J Zimmerman; Y Bersudsky; J Shapiro; R H Belmaker; G Agam
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Inositol treatment raises CSF inositol levels.

Authors:  J Levine; A Rapaport; L Lev; Y Bersudsky; O Kofman; R H Belmaker; J Shapiro; G Agam
Journal:  Brain Res       Date:  1993-11-05       Impact factor: 3.252

8.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

9.  Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats.

Authors:  M B Williams; R S Jope
Journal:  Brain Res       Date:  1995-07-10       Impact factor: 3.252

10.  Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization.

Authors:  S Rahman; R S Neuman
Journal:  Brain Res       Date:  1993-12-24       Impact factor: 3.252

View more
  1 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.